Tag: Schizophrenia
Childhood BMI Linked to Increased Risk for Schizophrenia
Direct causal effect of childhood BMI on schizophrenia seen in Mendelian randomization analyses, independent of adulthood BMI
SNP rs13194504 AA Genotype Linked to Severity of Tardive Dyskinesia
AA genotype linked to reduced severity, but not occurrence, of TD; no association seen for rs210133 with TD occurrence, severity
Electroconvulsive Therapy Safe, Effective for Range of Serious Mental Illnesses
Serious complications are rare, with confusion and cognitive side effects most common
Probiotic, Vitamin D Supplementation Tied to Benefits With Schizophrenia
Improvements seen in cognition, cholesterol, blood sugar, and C-reactive protein
Schizophrenia Linked to Increased Risk for Subsequent CVD Events
Association between schizophrenia and cardiovascular disease events more pronounced in women than men
Many People With Schizophrenia Have Stable Cognition Over 20 Years
However, neurocognitive declines are seen in others, which is tied to other poor outcomes
Intensive Meditation Intervention Aids Schizophrenia Symptoms
Significant improvements seen at eight months for positive symptoms and hallucinations, delusions
Long-Acting Injectable Antipsychotics Cut Readmission for Schizophrenia
Reduction in 30-day readmission rate seen for schizophrenia or schizoaffective disorder with long-acting versus oral antipsychotics
Severe QT Prolongation Common in Users of Antipsychotic Medications
In a recent study, severe QT prolongation occurred in 13.0 percent of quetiapine and 14.2 percent of haloperidol users
Many With Psychosis Have Long-Term Functional Morbidity
Researchers found that few individuals with psychotic disorders have participated in vocational training